Expression level of c-FLIP versus fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells

被引:30
作者
Kataoka, T
Ito, M
Budd, RC
Tschopp, J
Nagai, K
机构
[1] Tokyo Inst Technol, Res Ctr Expt Biol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan
[2] Univ Vermont, Coll Med, Immunobiol Program, Burlington, VT 05405 USA
[3] Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland
基金
美国国家卫生研究院;
关键词
apoptosis; DNA damage; Fas/CD95; c-FLIP; p53;
D O I
10.1006/excr.2001.5438
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The caspase-8 inhibitor c-FLIP blocks death receptor-mediated cell death and plays an essential role in the regulation of lymphocyte homeostasis and the immune escape of tumors. The murine thymoma cell line EL-4 was resistant to Fas ligand (FasL)-induced apoptosis by constitutive expression of FLIP (L). Cycloheximide downregulated the expression of FLIP (L) and markedly sensitized EL-4 cells to FasL-induced apoptosis. In contrast, DNA-damaging agents sensitized EL-4 cells to FasL-induced cell death via an increase of cell-surface Fas without any influence on FLIP (L) expression. Enforced expression of transfected Fas rendered EL-4 cells highly susceptible to FasL-induced cell death. These findings demonstrate that susceptibility to FasL-induced cell death mainly depends on the expression level of c-FLIP versus cell-surface Fas. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:256 / 264
页数:9
相关论文
共 35 条
[1]  
Algeciras-Schimnich A, 1999, J IMMUNOL, V162, P5205
[2]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[3]   The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors [J].
Djerbi, M ;
Screpanti, V ;
Catrina, AI ;
Bogen, B ;
Biberfeld, P ;
Grandien, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :1025-1031
[4]   Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells [J].
Fukazawa, T ;
Fujiwara, T ;
Uno, F ;
Teraishi, F ;
Kadowaki, Y ;
Itoshima, T ;
Takata, Y ;
Kagawa, S ;
Roth, JA ;
Tschopp, J ;
Tanaka, N .
ONCOGENE, 2001, 20 (37) :5225-5231
[5]  
Fulda S, 2000, CANCER RES, V60, P3947
[6]   Bcl-2, Bcl-x(L) and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death [J].
Huang, DCS ;
Cory, S ;
Strasser, A .
ONCOGENE, 1997, 14 (04) :405-414
[7]   Inhibition of death receptor signals by cellular FLIP [J].
Irmler, M ;
Thome, M ;
Hahne, M ;
Schneider, P ;
Hofmann, B ;
Steiner, V ;
Bodmer, JL ;
Schroter, M ;
Burns, K ;
Mattmann, C ;
Rimoldi, D ;
French, LE ;
Tschopp, J .
NATURE, 1997, 388 (6638) :190-195
[8]   The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways [J].
Kataoka, T ;
Budd, RC ;
Holler, N ;
Thome, M ;
Martinon, F ;
Irmler, M ;
Burns, K ;
Hahne, M ;
Kennedy, N ;
Kovacsovics, M ;
Tschopp, J .
CURRENT BIOLOGY, 2000, 10 (11) :640-648
[9]  
Kataoka T, 1998, J IMMUNOL, V161, P3936
[10]   NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling [J].
Kreuz, S ;
Siegmund, D ;
Scheurich, P ;
Wajant, H .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (12) :3964-3973